Cargando…
Early-stage corneal toxicity secondary to high-dose systemic cytarabine: a case report
BACKGROUND: High-dose systemic cytarabine chemotherapy may cause fine corneal opacities and refractile microcysts, which are densely distributed in the center of the cornea. Most previous case reports on microcysts have been those following complaints of subjective symptoms, and the findings at the...
Autores principales: | Mito, Tsuyoshi, Takeda, Shun, Miyashita, Hisanori, Sasaki, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987088/ https://www.ncbi.nlm.nih.gov/pubmed/36879276 http://dx.doi.org/10.1186/s12886-023-02834-3 |
Ejemplares similares
-
Atezolizumab-induced bilateral anterior uveitis: A case report
por: Mito, Tsuyoshi, et al.
Publicado: (2021) -
Corneal Epithelial Microcysts due to High-Dose Cytarabine Administration in a Pediatric Acute Myeloid Leukemia Patient
por: Karapınar, Tuba Hilkay, et al.
Publicado: (2012) -
Retrospective Comparison of Fludarabine in Combination With Intermediate-Dose Cytarabine Versus High-Dose Cytarabine As Consolidation Therapies for Acute Myeloid Leukemia
por: Zhang, Wenjun, et al.
Publicado: (2014) -
PB1838: TOXICITY AND OUTCOME OF HIGH DOSE CYTARABINE (18 G/M2) FOR AML CONSOLIDATION.
por: Lopes, L., et al.
Publicado: (2022) -
Cytarabine-Induced Corneal Toxicity: Clinical Features and Relief of Symptoms with Loteprednol Etabonate 0.5% in Two Patients
por: Özcan, Gökçen, et al.
Publicado: (2021)